ArticleJournal of eating disorders2025
Patients with anorexia nervosa have an increased burden of rare, damaging mutations in the BBOX1 gene.
Article in Journal of eating disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Shared and distinct genetic architectures of eating disorders and obesity: From monogenic causes to polygenic risk.Reviews in endocrine & metabolic disorders · 2026Review
- Carnitine dysregulation in diabetic kidney disease: from pathogenic mechanism to precision biomarker.Journal of translational medicine · 2026Review
- Metabolic regulation of synaptic plasticity in anorexia nervosa.Frontiers in synaptic neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeople with anorexia nervosa (AN) exhibit a strong aversion to eating calorically dense foods, especially those high in fat. It has previously been reported that these patients display altered metabolism of fatty acids, however it is unclear if these metabolic disturbances represent a primary biological substrate underlying predisposition to restrictive eating behaviors or occur secondarily to malnutrition.
methodsWe report the frequency of rare (minor allele frequency < 1%), damaging (CADD > 15) mutations in the BBOX1 gene of 183 patients with anorexia nervosa who received whole exome sequencing (WES) as part of their psychiatric evaluation. The observed frequency from our cohort was then compared to the rate of rare, damaging mutations in BBOX1 reported in the gnomAD database to determine if there was an excessive burden of damaging mutations.
resultsThe 11-27127338-G-A single nucleotide polymorphism in BBOX1 was observed to be shared by four sisters with a history of AN. Subsequent analysis found that this variant was also present in five out of 182 patients who had WES results. Six more unrelated patients out of 182 were found to have one of five additional rare, damaging mutations in BBOX1. In total, 12 out of 183 patients (6.6%) with AN were found to have a rare, damaging mutation in BBOX1 compared to an expected count of 4.4 (2.4%) from the gnomAD database (odds ratio 2.86; p = 0.0117).
conclusionsPatients with a history of AN have an increased burden of rare, damaging mutations in the BBOX1 gene. Because BBOX1 is required for synthesis of carnitine, a nutrient required for transport of long-chain fatty acids into the mitochondria for beta-oxidation, this finding suggests that impaired utilization of long-chain fatty acids may increase the risk of developing AN in a subset of patients. Identification of this group of patients by genetic or blood testing may lead to improved treatment outcomes and/or secondary prevention of relapse.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.